Search Results - david mcnabb

4 Results Sort By:
Engineered Fibroblast Growth Factor for Enhanced Wound Healing
Technology # 16-06A technology for Enhanced Wound HealingFibroblast Growth Factor (FGF) is a naturally occurring substance in the body that has many roles. One of them is to help heal wounds, FGF causes the wound to grow new blood vessels and new nerves. Currently FGF is used commercially to help in the healing of wounds, however, the version of FGF...
Published: 12/22/2015   |   Inventor(s): Suresh Kumar, Rebecca Kerr, Srinivas Jayanthi, David Mcnabb, David Zaharoff, Kartik Balachandran, Bhanuprasanth Koppolu
Category(s): Medical, Biotechnology, Pharmaceutical, All
Improved Green Fluorescent Protein for Protein Manufacturing
Technology # 16-05Technology related to Green Fluorescent Protein Manufacturing When manufacturing proteins from bacteria that has DNA that has been engineered to produce a target protein, it is necessary to also engineer a tag onto the end of the target protein strand. The tag allows the target protein to be distinguished from the other non-target...
Published: 12/10/2015   |   Inventor(s): Robert Beitle, Suresh Thallapuranam, Joshua Sakon, David Mcnabb, Rudra Mukherjee
Category(s): Medical, Biotechnology, Pharmaceutical, All, Food Science & Nutrition, Food Systems
Removal of Low Molecular Weight Heparin as a Treatment for Heparin Overdose
Technology # 14-04A Technology as a Treatment for Heparin OverdoseHeparin is an anti-coagulant that is commonly used in surgery to prevent blood from clotting during procedures such as kidney dialysis, heart bypass surgery, stent implementation, indwelling catheters and knee and hip replacements. In about 5% of the cases of heparin usage, the patients...
Published: 9/24/2015   |   Inventor(s): Suresh Thallapuranam, Srinivas Jayanthi, Jaqueline Morris, Alicia Brown, David Mcnabb, Ralph Henry
Category(s): Medical, Biotechnology, All, Pharmaceutical
Advanced Anti-Fungal Agent
Technology # 09-35 (Related to # 10-34)An Advanced Anti-Fungal AgentRecent studies indicate that the mortality rate for people with compromised immune systems who contract systemic fungal infections is 38 percent. In the US alone, this group, consisting of those with HIV, cancer, bone marrow transplant and organ transplant patients, number 9 million....
Published: 3/5/2014   |   Inventor(s): Suresh Kumar, Anna Daily, David Mcnabb
Category(s): Medical, Biotechnology, All
© 2020. All Rights Reserved. Powered by Inteum